Eagle Pharmaceuticals Inc sell Piper Sandler
Start price
09.08.23
/
50%
€17.90
Target price
09.08.24
-
Performance (%)
-75.20%
Price
08.05.24
€4.44
Summary
This prediction is currently active. Massive losses of -75.20% have been the result for the SELL prediction by Piper_Sandler. This prediction currently runs until 09.08.24. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eagle Pharmaceuticals Inc | 15.625% | 15.625% |
| iShares Core DAX® | 4.094% | 3.543% |
| iShares Nasdaq 100 | 1.424% | 0.512% |
| iShares Nikkei 225® | -1.572% | -4.633% |
| iShares S&P 500 | 1.822% | 0.963% |
Comments by Piper_Sandler for this prediction
In the thread Eagle Pharmaceuticals Inc diskutieren
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Ratings data for EGRX provided by MarketBeat